AtriCure, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| ATRC | PLSE | ANGO | MMSI | KMTS | ICUI | |
|---|---|---|---|---|---|---|
| Market cap | 3.33B | 4.07B | 515.17M | 5.43B | 1.82B | 4.32B |
| P/E (TTM) | 211.4 | — | — | 33.9 | — | 145.1 |
| Forward P/E | 154.0 | -48.8 | -108.1 | 19.4 | -14.8 | 17.9 |
| Price/book | 6.0 | 40.6 | 3.2 | 3.1 | 8.1 | 2.0 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +86.91% | +220.84% | −1.51% | −3.39% | +9.47% | +27.05% |
| Today | +8.48% | +9.31% | +4.43% | +7.69% | +5.14% | +6.67% |
The closest companies by business and industry (Medical Instruments & Supplies). Prices may be delayed up to 15 min.
Latest news
All ATRC news ›AtriCure projects 2026 adjusted EBITDA of $91M-$94M as it targets BoxX-NoAF enrollment completion by year-end
AtriCure Q3 2026 earnings: revenue rose 15%, EBITDA outlook increased, and BoxX-NoAF nears enrollment amid market headwinds. Earnings Call Insights: AtriCure (ATRC) Q3 2026 - CEO Michael H. Carrel opened by reporting “worldwide revenue of…
AtriCure Reports Third Quarter 2026 Financial Results
Third Quarter 2026 Financial Results Adjusted EBITDA for the third quarter 2026 was $26.8 million, an increase of $9.0 million or 51% from the third quarter 2025. For the third quarter 2026, adjusted earnings per share was $0.18, compared…
AtriCure (NASDAQ:ATRC) Stock Price Target Raised at JPMorgan Chase & Co.
Posted by Sarita Garza on Nov 4th, 2026 AtriCure (NASDAQ:ATRC – Get Free Report) had its price objective upped by analysts at JPMorgan Chase & Co. from $36.00 to $62.00 in a report released on Wednesday, Benzinga reports. The firm…
AtriCure, Inc. (ATRC) Q3 2026 Earnings Call Transcript
AtriCure, Inc. (ATRC) Q3 2026 Earnings Call November 3, 2026 4:30 PM EST Michael H. Carrel - CEO, President & DirectorAngela Wirick - Chief Financial Officer Good afternoon, and welcome to AtriCure's Third Quarter 2026 Earnings Conference…
AtriCure Non-GAAP EPS of $0.18 beats by $0.17, revenue of $154.5M beats by $3.31M
AtriCure Q3 earnings beat on EPS and revenue, with upbeat 2026 guidance and cash generation outlook. Full year 2026 revenue is now projected to be approximately $606 million to $610 million, and management also projects full year 2026…
AtriCure, Inc. Stock 12‑Month Price Target Raised to $64.86, Implies 7% Upside
TradingView AtriCure, Inc. Stock 12‑Month Price Target Raised to $64.86, Implies 7% Upside - According to estimates from 7 analysts, AtriCure, Inc. stock's average price target has risen from $61.71 to $64.86, with forec
AtriCure to Participate at Upcoming Investor Conferences
Published on 10/26/2026 at 08:01 am EDT AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management,…
Atricure Scores Relative Strength Rating Upgrade; Hits Key Benchmark
A Relative Strength Rating upgrade for Atricure shows improving technical performance. RESEARCH: IBD's 50 Most Sustainable Companies For 2026 When considering what names to put on your watch list, focus on stocks with an 80 or higher RS…
AtriCure, Inc. (NASDAQ:ATRC) Stock Has Average Price Target of $54.10 According to Brokerages
Posted by Danessa Lincoln on Oct 24th, 2026 View Our Latest Report on AtriCure ATRC stock opened at $58.97 on Wednesday. The company has a market cap of $3.00 billion, a PE ratio of 257.83 and a beta of 1.24. The business has a 50-day…
Citizens maintains Market Outperform rating on AtriCure, $68 price target
Citizens maintained their Market Outperform rating on AtriCure's stock with a price target of $68.00. The price target implies an upside of 17.9% from the Oct 20 close of $57.67. Strong Clinical Trial Progress: AtriCure's ongoing clinical…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- seekingalpha.com3
- stocktitan.net3
- themarketsdaily.com3
- biospace.com2
- tradingview.com2
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 18 articles, not a forecast.